Skip to content

Intuitive Surgical ISRG Noncontrolling interests in subsidiaries

Noncontrolling interests in subsidiaries at other companies

Boston Scientific logo
Boston ScientificBSX
$240M+3.0%
Medtronic logo
MedtronicMDT
STERIS logo
STERISSTE
Fortive logo
FortiveFTV
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH

Other financials

Income statement

See full
Revenue$2.8B+23.0%
Gross profit$1.8B+25.6%
Operating income$855.3M+47.9%
Net income$821.5M+17.6%
EPS (diluted)$2.28+18.8%

Balance sheet

See full
Cash & equivalents$2.1B-21.6%
Total equity$17.5B+2.2%
Total assets$20.1B+4.6%

Cash flow

See full
Operating cash flow$911.9M+56.8%
CapEx$103.3M-11.4%
Free cash flow$808.6M+73.9%

Valuation

See full
Market cap$142.44B-7.7%
P/E47.8×-14.5×
P/S13.5×-4.3×

Profitability

See full
Gross margin66.3%-0.8pp
Operating margin30.5%+2.3pp
Net margin28.2%-0.3pp

Returns & leverage

See full
Return on equity17.2%+1.3pp
Debt / equity0.0×
Current ratio4.6×-0.4×

Where this comes from

Reported directly by Intuitive Surgical in its filing.

Tagged under the XBRL concept us-gaap:MinorityInterest.

The official record: Intuitive Surgical’s 10-Q, filed April 22, 2026, on SEC EDGAR. View the filing →

Ask your AI about Intuitive Surgical's noncontrolling interests in subsidiaries.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Intuitive Surgical's noncontrolling interests in subsidiaries?
Intuitive Surgical (ISRG) reported noncontrolling interests in subsidiaries of $122.7M in Q1 2026.
How has Intuitive Surgical's noncontrolling interests in subsidiaries changed year-over-year?
Intuitive Surgical's noncontrolling interests in subsidiaries increased by 21.1% year-over-year, from $101.3M to $122.7M.
What is the long-term trend for Intuitive Surgical's noncontrolling interests in subsidiaries?
Over 5 years (2020 to 2025), Intuitive Surgical's noncontrolling interests in subsidiaries has grown at a 33.7% compound annual growth rate (CAGR), from $27.6M to $117.7M.